Chipping Away at Blood-Brain-Barrier Modeling

Area of Science:

• Biotechnology
• Drug Discovery
• Neuroscience

Background:

• The blood-brain barrier (BBB) presents a significant challenge for drug delivery to the central nervous system.
• Existing models often fail to fully replicate the complexity and physiological relevance of the human BBB.

Purpose of the Study:

• To develop a fully human in vitro blood-brain barrier model.
• To create a platform for accurate drug permeability prediction.
• To enable disease modeling and advance drug screening for neurological conditions.

Main Methods:

• Development of a microfluidic chip system.
• Utilized patient-derived tissue for model construction.
• Perfusion of the chip with whole blood.

Main Results:

• The human BBB chip accurately predicts drug permeability.
• The model successfully recapitulates disease-specific BBB defects.
• Demonstrated the platform's utility for drug screening and disease modeling.

Conclusions:

• The developed blood-brain barrier chip offers a robust and predictive model for pharmaceutical research.
• This platform facilitates personalized medicine approaches by using patient-derived tissues.
• Advances in in vitro modeling are crucial for accelerating the development of treatments for brain disorders.